Search

everythinglearnresearchcommunity

for

Search:↓

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The mFG score is effective for diagnosing hirsutism.

PCOS-related infertility is managed with lifestyle changes and medications.

Plant compounds may help manage PCOS, endometriosis, and menstrual issues.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Plant-based therapies, like Aloe Vera and Cinnamon, may help manage PCOS symptoms with fewer side effects.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Age, race, family history, and certain genetic factors increase prostate cancer risk.